Modulating neuroinflammation through electroacupuncture: Mechanistic insights and pharmacological synergies [0.03%]
电针调节神经炎症的作用机制及药理协同作用的见解
Salvador Quiroz-González,Erika Elizabeth Rodríguez-Torres,Ismael Jiménez-Estrada
Salvador Quiroz-González
Neuroinflammation plays a central role in the pathogenesis of numerous neurological and neurodegenerative diseases, driven by complex interactions among glial activation, cytokine release, blood-brain barrier (BBB) dysfunction, and autonomi...
Pharmacoutilization data-driven artificial intelligence-assisted diagnosis algorithm to improve the pharmacological treatment of pain and agitation in patients suffering from severe dementia [0.03%]
基于药理学利用数据的人工智能辅助诊断算法，改善痴呆症严重患者疼痛和焦虑的药物治疗
Damiana Scuteri,Carlo Adornetto,Gianluigi Greco et al.
Damiana Scuteri et al.
The number of diagnoses and drug prescriptions for dementia patients is poorly available. Delay in the diagnosis of Alzheimer's disease (AD), for which missed diagnoses amount to over half cases, and undertreatment of chronic and neuropathi...
Recent innovations in clinical trial design for inflammatory bowel disease [0.03%]
近年来炎症性肠病临床试验设计的新进展
Rocio Sedano,Christopher Ma,Vipul Jairath
Rocio Sedano
Clinical trial design in inflammatory bowel disease (IBD) is evolving to address challenges in drug development and approvals. For clinical development, notable innovations include Bayesian designs, adaptive designs, integrated-phase trials...
Kristina Lorenz,Jürgen Schrader
Kristina Lorenz
Smart solutions for tough infections: The rise of next-gen transdermal drug delivery [0.03%]
应对难治性感染的智能解决方案：下一代透皮给药系统的发展趋势
Sachin S Mali,Prakash D Jadhav,Sameer J Nadaf
Sachin S Mali
Corrigendum to "From "contraindicated" to "first line" - Current mechanistic insights beyond canonical β-receptor signaling" [COPHAR 76 (2024) 102458] [0.03%]
“从‘禁忌’到‘一线’——超越经典β受体信号转导的当前机制见解” COPHAR 76 (2024) 102458 的勘误表
Theresa Brand,Ann-Kathrin Lukannek,Valérie Jahns et al.
Theresa Brand et al.
Published Erratum
Current opinion in pharmacology. 2025 Jul 19:84:102550. DOI:10.1016/j.coph.2025.102550 2025
Corrigendum to "Challenges in formulating transdermal systems for treating chronic skin infections" [Curr Opin Pharmacol 83 (2025) 102540] [0.03%]
关于“治疗慢性皮肤感染经皮给药系统制剂挑战”的勘误[现论药理学83（2025）102540]
Akshay Ramchandra Yadav,Shital Aniket Shinde,Shubhangi B Sutar et al.
Akshay Ramchandra Yadav et al.
Published Erratum
Current opinion in pharmacology. 2025 Jul 16:84:102554. DOI:10.1016/j.coph.2025.102554 2025
Ionic liquid choline and geranic acid-mediated topical drug delivery in skin tissue regeneration and neutralization of potential pathogens: A review [0.03%]
胆碱和香茅酸介导的离子液体经皮药物输送在皮肤组织再生和潜在病原体中和方面的应用：综述
Popat Mohite,Shubham Munde,Aarati Budar et al.
Popat Mohite et al.
Ionic liquids have emerged as promising vehicles for drug delivery, with choline and geranic acid (CAGE) demonstrating exceptional potential in topical formulation for skin tissue regeneration and antimicrobial properties. CAGE exhibits uni...
Swati Udugade,Babaso V Udugade,Sanket R Patil et al.
Swati Udugade et al.
Nanotechnology-enhanced transdermal drug delivery systems (NETS) show great potential in treating infectious diseases by improving drug penetration, stability, and bioavailability. Unlike traditional methods, NETS overcome skin barrier limi...
Transdermal delivery of antibacterial peptides in the management of methicillin-resistant Staphylococcus aureus [0.03%]
治疗耐甲氧西林金黄色葡萄球菌的抗菌肽经皮输送疗法
Shivraj Sangappa Shivpuje,Durgacharan A Bhagwat,Pankaj Ashok Jadhav et al.
Shivraj Sangappa Shivpuje et al.
Bacterial antimicrobial resistance (AMR) is of major public concern around the globe that arises when bacteria which earlier responded to the antibiotic therapy no longer respond to the same therapy and become resistant. The AMR has emerged...